Metastatic Lung Cancer | Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum - a podcast by Dr Neil Love
from 2019-12-19T18:48:39
::
::
Proceedings from a CME symposium held during the IASLC 2019 North America Conference on Lung Cancer. Featuring perspectives from moderator Dr Joel W Neal and faculty members Drs Nasser H Hanna, Leora Horn and Lecia V Sequist:
- Introduction (00:00)
- Evolving Therapeutic Algorithms in Small Cell Lung Cancer (SCLC) (1:04)
- Optimal Therapeutic Approaches for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (21:55)
- Management of NSCLC with ALK Rearrangements (35:24)
- Current and Future Role of Existing and Emerging ROS1 Inhibitors (45:16)
- Treatment of Metastatic NSCLC with Other Targetable Tumor Mutations (56:06)
- Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with Other Systemic Therapies for Metastatic NSCLC (1:15:41)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love